AstraZeneca former Chief Gagandeep Singh joins Boehringer Ingelheim as MD, Head of Human Pharma India Ruchika Sharma26 Jun 2023 5:12 PM ISTGagandeep Singh joins Boehringer Ingelheim from AstraZeneca, where he was the Managing Director for India and Africa Cluster Head.
Boehringer Ingelheim India joins hands with Maharashtra Govt to strengthen stroke care in state Ruchika Sharma22 Jun 2023 2:30 PM ISTAs part of the MoU, the government will develop new stroke centres in the future, with the availability of a physician, 24*7 CT scan and thrombolytic...
Eli Lilly-Boehringer Ingelheim bags USFDA nod for Type 2 diabetes drugs Jardiance, Synjardy for children Ruchika Sharma21 Jun 2023 4:30 PM ISTUnited States: The U.S. Food and Drug Administration (FDA) on Tuesday approved Eli Lilly and partner Boehringer Ingelheim's drugs Jardiance and...
Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim Ruchika Sharma21 Jun 2023 1:30 PM ISTThere is no evidence of consumer harm from real world use of Zantac as a result of any NDMA contamination.
Boehringer Ingelheim starts clinical development of fibrotic diseases treatment Ruchika Sharma10 May 2023 4:30 PM ISTIL-11 plays a key role in fibrosis across multiple organs and pre-clinical studies have shown that anti-IL-11 treatment has the potential to stop -...
Boehringer Ingelheim Spesolimab bags USFDA Breakthrough Therapy Designation for prevention of generalized pustular psoriasis flares Ruchika Sharma3 May 2023 2:30 PM ISTGeneralized pustular psoriasis is a rare and potentially life-threatening chronic neutrophilic skin disease characterized by flares of widespread...
Boehringer Ingelheim, Cognizant ink pact on Unified Cloud Platform to speed delivery of life saving therapies Ruchika Sharma13 April 2023 11:15 AM ISTBy bringing together Boehringer Ingelheim's clinical, regulatory, and quality functions onto this unified platform simultaneously, this holistic...
Heartburn drug: Sanofi expects decision on Zantac dispute with Boehringer in Q1 at earliest Ruchika Sharma5 Jan 2023 1:15 PM ISTOriginally marketed by a forerunner of GSK, the medicine has been sold at different times by companies including Pfizer, Boehringer, and Sanofi as...
Boehringer Ingelheim appoints Shashank Deshpande, Paola Casarosa to Board of Managing Directors Ruchika Sharma22 Dec 2022 12:45 PM ISTThe appointment to the Board of Managing Directors will be effective July 1, 2023 for Paola Casarosa and September 1, 2023 for Shashank Deshpande.
Boehringer Ingelheim gets European Commission approval for Generalized Pustular Psoriasis flares treatment Spesolimab Ruchika Sharma14 Dec 2022 2:15 PM ISTPeople living with GPP often do not receive a correct or timely diagnosis and may have their symptoms identified as other forms of psoriasis.
Boehringer Ingelheim gets USFDA nod for SPEVIGO to treat generalized pustular psoriasis flares Ruchika Sharma3 Sept 2022 11:00 AM ISTRidgefield: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (USFDA) has approved SPEVIGO, the first approved treatment...
Boehringer Ingelheim, Evotec and bioMérieux launch joint venture Aurobac Ruchika Sharma10 July 2022 2:00 PM ISTFrance: Boehringer Ingelheim, a research-driven biopharmaceutical company, the life science company Evotec SE and bioMérieux have announced that they...
